Allspring Global Investments Holdings LLC Takes $948,000 Position in The Joint Corp. (NASDAQ:JYNT)

Allspring Global Investments Holdings LLC acquired a new stake in The Joint Corp. (NASDAQ:JYNTGet Rating) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 14,437 shares of the company’s stock, valued at approximately $948,000. Allspring Global Investments Holdings LLC owned about 0.10% of Joint at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. BNP Paribas Arbitrage SA lifted its stake in shares of Joint by 193.1% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 13,690 shares of the company’s stock valued at $1,342,000 after purchasing an additional 9,019 shares during the last quarter. Amalgamated Bank lifted its stake in shares of Joint by 3.2% in the 3rd quarter. Amalgamated Bank now owns 7,466 shares of the company’s stock valued at $732,000 after purchasing an additional 233 shares during the last quarter. Ensign Peak Advisors Inc lifted its stake in shares of Joint by 121.1% during the 3rd quarter. Ensign Peak Advisors Inc now owns 12,600 shares of the company’s stock worth $1,235,000 after acquiring an additional 6,900 shares during the last quarter. Avondale Wealth Management bought a new stake in shares of Joint during the 4th quarter worth approximately $181,000. Finally, New York State Teachers Retirement System lifted its stake in shares of Joint by 33.5% during the 3rd quarter. New York State Teachers Retirement System now owns 5,043 shares of the company’s stock worth $494,000 after acquiring an additional 1,266 shares during the last quarter. 86.71% of the stock is owned by institutional investors and hedge funds.

In other Joint news, CFO Jake Singleton bought 1,515 shares of the company’s stock in a transaction that occurred on Wednesday, March 16th. The shares were purchased at an average cost of $33.00 per share, for a total transaction of $49,995.00. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Peter D. Holt bought 1,500 shares of the company’s stock in a transaction that occurred on Wednesday, March 16th. The shares were acquired at an average price of $33.24 per share, for a total transaction of $49,860.00. The disclosure for this purchase can be found here. Company insiders own 4.60% of the company’s stock.

Shares of NASDAQ:JYNT opened at $32.01 on Friday. The Joint Corp. has a 12-month low of $29.84 and a 12-month high of $111.06. The business’s fifty day simple moving average is $37.61 and its 200-day simple moving average is $59.77. The company has a market capitalization of $461.36 million, a PE ratio of 66.69 and a beta of 1.27. The company has a current ratio of 1.25, a quick ratio of 1.25 and a debt-to-equity ratio of 0.07.

Joint (NASDAQ:JYNTGet Rating) last announced its quarterly earnings results on Thursday, February 24th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.08 by ($0.07). Joint had a net margin of 8.82% and a return on equity of 26.30%. The company had revenue of $22.43 million during the quarter, compared to analysts’ expectations of $22.21 million. During the same quarter in the prior year, the business posted $0.12 earnings per share. Research analysts predict that The Joint Corp. will post 0.33 EPS for the current year.

A number of equities research analysts recently issued reports on JYNT shares. StockNews.com raised Joint from a “sell” rating to a “hold” rating in a research note on Friday. Lake Street Capital decreased their price target on Joint from $150.00 to $100.00 in a research note on Friday, February 25th. Zacks Investment Research lowered Joint from a “buy” rating to a “sell” rating in a research note on Tuesday, March 1st. DA Davidson decreased their price target on Joint from $128.00 to $69.00 and set a “buy” rating for the company in a research note on Friday, February 25th. Finally, B. Riley reduced their price objective on Joint from $125.00 to $88.00 in a report on Friday, February 25th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Joint has an average rating of “Buy” and an average price target of $85.33.

Joint Company Profile (Get Rating)

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States.

Featured Articles

Institutional Ownership by Quarter for Joint (NASDAQ:JYNT)

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.